Nexvet Biopharma plc Insider Trading for February 2015
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Nexvet Biopharma plc.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in Nexvet Biopharma plc for February 2015.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb 11 2015 | NVET | Nexvet Biopharma p ... | Akubra Investors, LLC | 10% Owner | Option Exercise | C | 0.00 | 1,799,996 | 0 | 0 | |
| Feb 11 2015 | NVET | Nexvet Biopharma p ... | Akubra Investors, LLC | 10% Owner | Option Exercise | C | 0.00 | 1,405,130 | 0 | 0 | |
| Feb 11 2015 | NVET | Nexvet Biopharma p ... | Akubra Investors, LLC | 10% Owner | Option Exercise | C | 0.00 | 142,424 | 0 | 0 | |
| Feb 11 2015 | NVET | Nexvet Biopharma p ... | Akubra Investors, LLC | 10% Owner | Option Exercise | C | 0.00 | 169,530 | 0 | 0 | |
| Feb 11 2015 | NVET | Nexvet Biopharma p ... | Akubra Investors, LLC | 10% Owner | Option Exercise | C | 0.00 | 82,912 | 0 | 0 | |
| Feb 11 2015 | NVET | Nexvet Biopharma p ... | Akubra Investors, LLC | 10% Owner | Option Exercise | C | 0.00 | 622,208 | 0 | 0 | |
| Feb 11 2015 | NVET | Nexvet Biopharma p ... | Akubra Investors, LLC | 10% Owner | Option Exercise | C | 0.00 | 611,124 | 0 | 0 | |
| Feb 11 2015 | NVET | Nexvet Biopharma p ... | Akubra Investors, LLC | 10% Owner | Option Exercise | C | 0.00 | 566,664 | 0 | 0 | |
| Feb 11 2015 | NVET | Nexvet Biopharma p ... | Akubra Investors, LLC | 10% Owner | Grant | A | 0.00 | 700,000 | 0 | 2,499,996 | 1.8 M to 2.5 M (+38.89 %) |
| Feb 11 2015 | NVET | Nexvet Biopharma p ... | Akubra Investors, LLC | 10% Owner | Buy | C | 0.00 | 1,799,996 | 0 | 1,799,996 | 0 to 1.8 M |
| Feb 11 2015 | NVET | Nexvet Biopharma p ... | Akubra Investors, LLC | 10% Owner | Grant | A | 10.00 | 546,441 | 5,464,410 | 1,951,571 | 1.4 M to 2 M (+38.89 %) |
| Feb 11 2015 | NVET | Nexvet Biopharma p ... | Akubra Investors, LLC | 10% Owner | Buy | C | 0.00 | 1,405,130 | 0 | 1,405,130 | 0 to 1.4 M |
| Feb 11 2015 | NVET | Nexvet Biopharma p ... | Akubra Investors, LLC | 10% Owner | Grant | A | 10.00 | 55,387 | 553,870 | 197,811 | 142.4 K to 197.8 K (+38.89 %) |
| Feb 11 2015 | NVET | Nexvet Biopharma p ... | Akubra Investors, LLC | 10% Owner | Buy | C | 0.00 | 142,424 | 0 | 142,424 | 0 to 142.4 K |
| Feb 11 2015 | NVET | Nexvet Biopharma p ... | Akubra Investors, LLC | 10% Owner | Grant | A | 10.00 | 65,928 | 659,280 | 235,458 | 169.5 K to 235.5 K (+38.89 %) |
| Feb 11 2015 | NVET | Nexvet Biopharma p ... | Akubra Investors, LLC | 10% Owner | Buy | C | 0.00 | 169,530 | 0 | 169,530 | 0 to 169.5 K |
| Feb 11 2015 | NVET | Nexvet Biopharma p ... | Akubra Investors, LLC | 10% Owner | Grant | A | 10.00 | 32,244 | 322,440 | 115,156 | 82.9 K to 115.2 K (+38.89 %) |
| Feb 11 2015 | NVET | Nexvet Biopharma p ... | Akubra Investors, LLC | 10% Owner | Buy | C | 0.00 | 82,912 | 0 | 82,912 | 0 to 82.9 K |
| Feb 11 2015 | NVET | Nexvet Biopharma p ... | Akubra Investors, LLC | 10% Owner | Grant | A | 10.00 | 241,970 | 2,419,700 | 864,178 | 622.2 K to 864.2 K (+38.89 %) |
| Feb 11 2015 | NVET | Nexvet Biopharma p ... | Akubra Investors, LLC | 10% Owner | Buy | C | 0.00 | 622,208 | 0 | 622,208 | 0 to 622.2 K |
| Feb 11 2015 | NVET | Nexvet Biopharma p ... | Akubra Investors, LLC | 10% Owner | Grant | A | 10.00 | 237,659 | 2,376,590 | 848,783 | 611.1 K to 848.8 K (+38.89 %) |
| Feb 11 2015 | NVET | Nexvet Biopharma p ... | Akubra Investors, LLC | 10% Owner | Buy | C | 0.00 | 611,124 | 0 | 611,124 | 0 to 611.1 K |
| Feb 11 2015 | NVET | Nexvet Biopharma p ... | Akubra Investors, LLC | 10% Owner | Grant | A | 10.00 | 220,371 | 2,203,710 | 787,035 | 566.7 K to 787 K (+38.89 %) |
| Feb 11 2015 | NVET | Nexvet Biopharma p ... | Akubra Investors, LLC | 10% Owner | Buy | C | 0.00 | 566,664 | 0 | 566,664 | 0 to 566.7 K |
| Feb 11 2015 | NVET | Nexvet Biopharma p ... | FARALLON CAPITAL MANAGEMENT LL ... | 10% Owner | Option Exercise | C | 0.00 | 1,799,996 | 0 | 0 | |
| Feb 11 2015 | NVET | Nexvet Biopharma p ... | FARALLON CAPITAL MANAGEMENT LL ... | 10% Owner | Option Exercise | C | 0.00 | 1,405,130 | 0 | 0 | |
| Feb 11 2015 | NVET | Nexvet Biopharma p ... | FARALLON CAPITAL MANAGEMENT LL ... | 10% Owner | Option Exercise | C | 0.00 | 142,424 | 0 | 0 | |
| Feb 11 2015 | NVET | Nexvet Biopharma p ... | FARALLON CAPITAL MANAGEMENT LL ... | 10% Owner | Option Exercise | C | 0.00 | 169,530 | 0 | 0 | |
| Feb 11 2015 | NVET | Nexvet Biopharma p ... | FARALLON CAPITAL MANAGEMENT LL ... | 10% Owner | Option Exercise | C | 0.00 | 82,912 | 0 | 0 | |
| Feb 11 2015 | NVET | Nexvet Biopharma p ... | FARALLON CAPITAL MANAGEMENT LL ... | 10% Owner | Option Exercise | C | 0.00 | 622,208 | 0 | 0 | |
| Feb 11 2015 | NVET | Nexvet Biopharma p ... | FARALLON CAPITAL MANAGEMENT LL ... | 10% Owner | Option Exercise | C | 0.00 | 611,124 | 0 | 0 | |
| Feb 11 2015 | NVET | Nexvet Biopharma p ... | FARALLON CAPITAL MANAGEMENT LL ... | 10% Owner | Option Exercise | C | 0.00 | 566,664 | 0 | 0 | |
| Feb 11 2015 | NVET | Nexvet Biopharma p ... | FARALLON CAPITAL MANAGEMENT LL ... | 10% Owner | Grant | A | 0.00 | 700,000 | 0 | 2,499,996 | 1.8 M to 2.5 M (+38.89 %) |
| Feb 11 2015 | NVET | Nexvet Biopharma p ... | FARALLON CAPITAL MANAGEMENT LL ... | 10% Owner | Buy | C | 0.00 | 1,799,996 | 0 | 1,799,996 | 0 to 1.8 M |
| Feb 11 2015 | NVET | Nexvet Biopharma p ... | FARALLON CAPITAL MANAGEMENT LL ... | 10% Owner | Grant | A | 10.00 | 546,441 | 5,464,410 | 1,951,571 | 1.4 M to 2 M (+38.89 %) |
| Feb 11 2015 | NVET | Nexvet Biopharma p ... | FARALLON CAPITAL MANAGEMENT LL ... | 10% Owner | Buy | C | 0.00 | 1,405,130 | 0 | 1,405,130 | 0 to 1.4 M |
| Feb 11 2015 | NVET | Nexvet Biopharma p ... | FARALLON CAPITAL MANAGEMENT LL ... | 10% Owner | Grant | A | 10.00 | 55,387 | 553,870 | 197,811 | 142.4 K to 197.8 K (+38.89 %) |
| Feb 11 2015 | NVET | Nexvet Biopharma p ... | FARALLON CAPITAL MANAGEMENT LL ... | 10% Owner | Buy | C | 0.00 | 142,424 | 0 | 142,424 | 0 to 142.4 K |
| Feb 11 2015 | NVET | Nexvet Biopharma p ... | FARALLON CAPITAL MANAGEMENT LL ... | 10% Owner | Grant | A | 10.00 | 65,928 | 659,280 | 235,458 | 169.5 K to 235.5 K (+38.89 %) |
| Feb 11 2015 | NVET | Nexvet Biopharma p ... | FARALLON CAPITAL MANAGEMENT LL ... | 10% Owner | Buy | C | 0.00 | 169,530 | 0 | 169,530 | 0 to 169.5 K |
| Feb 11 2015 | NVET | Nexvet Biopharma p ... | FARALLON CAPITAL MANAGEMENT LL ... | 10% Owner | Grant | A | 10.00 | 32,244 | 322,440 | 115,156 | 82.9 K to 115.2 K (+38.89 %) |
| Feb 11 2015 | NVET | Nexvet Biopharma p ... | FARALLON CAPITAL MANAGEMENT LL ... | 10% Owner | Buy | C | 0.00 | 82,912 | 0 | 82,912 | 0 to 82.9 K |
| Feb 11 2015 | NVET | Nexvet Biopharma p ... | FARALLON CAPITAL MANAGEMENT LL ... | 10% Owner | Grant | A | 10.00 | 241,970 | 2,419,700 | 864,178 | 622.2 K to 864.2 K (+38.89 %) |
| Feb 11 2015 | NVET | Nexvet Biopharma p ... | FARALLON CAPITAL MANAGEMENT LL ... | 10% Owner | Buy | C | 0.00 | 622,208 | 0 | 622,208 | 0 to 622.2 K |
| Feb 11 2015 | NVET | Nexvet Biopharma p ... | FARALLON CAPITAL MANAGEMENT LL ... | 10% Owner | Grant | A | 10.00 | 237,659 | 2,376,590 | 848,783 | 611.1 K to 848.8 K (+38.89 %) |
| Feb 11 2015 | NVET | Nexvet Biopharma p ... | FARALLON CAPITAL MANAGEMENT LL ... | 10% Owner | Buy | C | 0.00 | 611,124 | 0 | 611,124 | 0 to 611.1 K |
| Feb 11 2015 | NVET | Nexvet Biopharma p ... | FARALLON CAPITAL MANAGEMENT LL ... | 10% Owner | Grant | A | 10.00 | 220,371 | 2,203,710 | 787,035 | 566.7 K to 787 K (+38.89 %) |
| Feb 11 2015 | NVET | Nexvet Biopharma p ... | FARALLON CAPITAL MANAGEMENT LL ... | 10% Owner | Buy | C | 0.00 | 566,664 | 0 | 566,664 | 0 to 566.7 K |
| Feb 10 2015 | NVET | Nexvet Biopharma p ... | ONE FUNDS MANAGEMENT LTD ATF A ... | 10% Owner | Option Exercise | C | 0.00 | 242,400 | 0 | 0 | |
| Feb 10 2015 | NVET | Nexvet Biopharma p ... | ONE FUNDS MANAGEMENT LTD ATF A ... | 10% Owner | Option Exercise | C | 0.00 | 530,972 | 0 | 0 | |
| Feb 10 2015 | NVET | Nexvet Biopharma p ... | ONE FUNDS MANAGEMENT LTD ATF A ... | 10% Owner | Buy | P | 10.00 | 100,000 | 1,000,000 | 873,372 | 773.4 K to 873.4 K (+12.93 %) |
| Feb 10 2015 | NVET | Nexvet Biopharma p ... | ONE FUNDS MANAGEMENT LTD ATF A ... | 10% Owner | Buy | C | 0.00 | 242,400 | 0 | 773,372 | 531 K to 773.4 K (+45.65 %) |
| Feb 10 2015 | NVET | Nexvet Biopharma p ... | ONE FUNDS MANAGEMENT LTD ATF A ... | 10% Owner | Buy | C | 0.00 | 530,972 | 0 | 530,972 | 0 to 531 K |
| Feb 10 2015 | NVET | Nexvet Biopharma p ... | Wald Graeme | Director | Option Exercise | C | 0.00 | 7,548 | 0 | 0 | |
| Feb 10 2015 | NVET | Nexvet Biopharma p ... | Wald Graeme | Director | Option Exercise | C | 0.00 | 6,176 | 0 | 0 | |
| Feb 10 2015 | NVET | Nexvet Biopharma p ... | Wald Graeme | Director | Buy | C | 0.00 | 7,548 | 0 | 7,548 | 0 to 7.5 K |
| Feb 10 2015 | NVET | Nexvet Biopharma p ... | Wald Graeme | Director | Buy | C | 0.00 | 6,176 | 0 | 6,176 | 0 to 6.2 K |
| Feb 10 2015 | NVET | Nexvet Biopharma p ... | Lismore Damian T. | Chief Financial Off ... | Option Exercise | C | 0.00 | 13,724 | 0 | 0 | |
| Feb 10 2015 | NVET | Nexvet Biopharma p ... | Lismore Damian T. | Chief Financial Off ... | Buy | C | 0.00 | 13,724 | 0 | 13,724 | 0 to 13.7 K |
| Feb 10 2015 | NVET | Nexvet Biopharma p ... | Heffernan Mark | Chief Executive Off ... | Option Exercise | C | 0.00 | 4,424 | 0 | 0 | |
| Feb 10 2015 | NVET | Nexvet Biopharma p ... | Heffernan Mark | Chief Executive Off ... | Buy | C | 0.00 | 4,424 | 0 | 234,383 | 230 K to 234.4 K (+1.92 %) |
| Feb 10 2015 | NVET | Nexvet Biopharma p ... | GILES COLIN | VP Clinical&Regulat ... | Option Exercise | C | 0.00 | 6,352 | 0 | 0 | |
| Feb 10 2015 | NVET | Nexvet Biopharma p ... | GILES COLIN | VP Clinical&Regulat ... | Buy | C | 0.00 | 6,352 | 0 | 12,645 | 6.3 K to 12.6 K (+100.94 %) |
| Feb 10 2015 | NVET | Nexvet Biopharma p ... | Farrell Geraldine T | VP Operations & Gen ... | Option Exercise | C | 0.00 | 1,696 | 0 | 0 | |
| Feb 10 2015 | NVET | Nexvet Biopharma p ... | Farrell Geraldine T | VP Operations & Gen ... | Option Exercise | C | 0.00 | 56 | 0 | 0 | |
| Feb 10 2015 | NVET | Nexvet Biopharma p ... | Farrell Geraldine T | VP Operations & Gen ... | Option Exercise | C | 0.00 | 36 | 0 | 0 | |
| Feb 10 2015 | NVET | Nexvet Biopharma p ... | Farrell Geraldine T | VP Operations & Gen ... | Buy | C | 0.00 | 1,696 | 0 | 7,891 | 6.2 K to 7.9 K (+27.38 %) |
| Feb 10 2015 | NVET | Nexvet Biopharma p ... | Farrell Geraldine T | VP Operations & Gen ... | Buy | C | 0.00 | 56 | 0 | 132 | 76 to 132 (+73.68 %) |
| Feb 10 2015 | NVET | Nexvet Biopharma p ... | Farrell Geraldine T | VP Operations & Gen ... | Buy | C | 0.00 | 36 | 0 | 76 | 40 to 76 (+90.00 %) |
| Feb 10 2015 | NVET | Nexvet Biopharma p ... | Brown Christopher Nigel | Director | Option Exercise | C | 0.00 | 8,800 | 0 | 0 | |
| Feb 10 2015 | NVET | Nexvet Biopharma p ... | Brown Christopher Nigel | Director | Buy | C | 0.00 | 8,800 | 0 | 8,800 | 0 to 8.8 K |
| Feb 10 2015 | NVET | Nexvet Biopharma p ... | ADAGE CAPITAL PARTNERS GP LLC | 10% Owner | Option Exercise | C | 0.00 | 600,000 | 0 | 0 | |
| Feb 10 2015 | NVET | Nexvet Biopharma p ... | ADAGE CAPITAL PARTNERS GP LLC | 10% Owner | Buy | C | 0.00 | 600,000 | 0 | 875,000 | 275 K to 875 K (+218.18 %) |
| Feb 10 2015 | NVET | Nexvet Biopharma p ... | ADAGE CAPITAL PARTNERS GP LLC | 10% Owner | Buy | P | 10.00 | 275,000 | 2,750,000 | 275,000 | 0 to 275 K |